Literature DB >> 30796971

Mitochondrial and calcium perturbations in rat CNS neurons induce calpain-cleavage of Parkin: Phosphatase inhibition stabilizes pSer65Parkin reducing its calpain-cleavage.

Hu Wang1, Fanny Cheung1, Anna C Stoll1, Patricia Rockwell1, Maria E Figueiredo-Pereira2.   

Abstract

Mitochondrial impairment and calcium (Ca++) dyshomeostasis are associated with Parkinson's disease (PD). When intracellular ATP levels are lowered, Ca++-ATPase pumps are impaired causing cytoplasmic Ca++ to be elevated and calpain activation. Little is known about the effect of calpain activation on Parkin integrity. To address this gap, we examined the effects of mitochondrial inhibitors [oligomycin (Oligo), antimycin and rotenone] on endogenous Parkin integrity in rat midbrain and cerebral cortical cultures. All drugs induced calpain-cleavage of Parkin to ~36.9/43.6 kDa fragments. In contrast, treatment with the proinflammatory prostaglandin J2 (PGJ2) and the proteasome inhibitor epoxomicin induced caspase-cleavage of Parkin to fragments of a different size, previously shown by others to be triggered by apoptosis. Calpain-cleaved Parkin was enriched in neuronal mitochondrial fractions. Pre-treatment with the phosphatase inhibitor okadaic acid prior to Oligo-treatment, stabilized full-length Parkin phosphorylated at Ser65, and reduced calpain-cleavage of Parkin. Treatment with the Ca++ ionophore A23187, which facilitates Ca++ transport across the plasma membrane, mimicked the effect of Oligo by inducing calpain-cleavage of Parkin. Removing extracellular Ca++ from the media prevented oligomycin- and ionophore-induced calpain-cleavage of Parkin. Computational analysis predicted that calpain-cleavage of Parkin liberates its UbL domain. The phosphagen cyclocreatine moderately mitigated Parkin cleavage by calpain. Moreover, the pituitary adenylate cyclase activating peptide (PACAP27), which stimulates cAMP production, prevented caspase but not calpain-cleavage of Parkin. Overall, our data support a link between Parkin phosphorylation and its cleavage by calpain. This mechanism reflects the impact of mitochondrial impairment and Ca++-dyshomeostasis on Parkin integrity and could influence PD pathogenesis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium; Calpain; Mitochondria; Parkin; Parkinson's disease; Phosphorylation

Mesh:

Substances:

Year:  2019        PMID: 30796971      PMCID: PMC6502656          DOI: 10.1016/j.bbadis.2019.02.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  90 in total

1.  The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity.

Authors:  Hye-Min Park; Goo-Young Kim; Min-Kyung Nam; Geun-Hye Seong; Chul Han; Kwang Chul Chung; Seongman Kang; Hyangshuk Rhim
Journal:  Biochem Biophys Res Commun       Date:  2009-07-23       Impact factor: 3.575

Review 2.  Evolution and physiological roles of phosphagen systems.

Authors:  W R Ellington
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

Review 3.  The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system.

Authors:  Robert T M Boudreau; David W Hoskin
Journal:  Int Immunopharmacol       Date:  2005-09       Impact factor: 4.932

Review 4.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

5.  Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.

Authors:  Brian M Dufty; Lisa R Warner; Sheng T Hou; Susan X Jiang; Teresa Gomez-Isla; Kristen M Leenhouts; Julia T Oxford; Mel B Feany; Eliezer Masliah; Troy T Rohn
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 6.  Calcium homeostasis, selective vulnerability and Parkinson's disease.

Authors:  C Savio Chan; Tracy S Gertler; D James Surmeier
Journal:  Trends Neurosci       Date:  2009-03-21       Impact factor: 13.837

Review 7.  Calcium signaling in Parkinson's disease.

Authors:  Tito Calì; Denis Ottolini; Marisa Brini
Journal:  Cell Tissue Res       Date:  2014-05-01       Impact factor: 5.249

8.  Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation.

Authors:  Agne Kazlauskaite; R Julio Martínez-Torres; Scott Wilkie; Atul Kumar; Julien Peltier; Alba Gonzalez; Clare Johnson; Jinwei Zhang; Anthony G Hope; Mark Peggie; Matthias Trost; Daan M F van Aalten; Dario R Alessi; Alan R Prescott; Axel Knebel; Helen Walden; Miratul M K Muqit
Journal:  EMBO Rep       Date:  2015-06-25       Impact factor: 8.807

Review 9.  The ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Salvatore Oddo
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

10.  C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction.

Authors:  Janin Lautenschläger; Amberley D Stephens; Giuliana Fusco; Florian Ströhl; Nathan Curry; Maria Zacharopoulou; Claire H Michel; Romain Laine; Nadezhda Nespovitaya; Marcus Fantham; Dorothea Pinotsi; Wagner Zago; Paul Fraser; Anurag Tandon; Peter St George-Hyslop; Eric Rees; Jonathan J Phillips; Alfonso De Simone; Clemens F Kaminski; Gabriele S Kaminski Schierle
Journal:  Nat Commun       Date:  2018-02-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.